Abstract
A tetradentate Schiff base ligand, L (L = N,N′-bis(1-(2-pyridyl)ethylidene)-2,2-dimethylpropane-1,3-diamine) was used in the preparation of a new mononuclear Zn(II) complex, [Zn(L)Cl]. The complex was structurally investigated by elemental analyses, spectroscopic studies and single crystal X-ray crystallography. Furthermore, to obtain insights into the structure, the ground state geometry of zinc complex cation was examined by dispersion corrected DFT method i.e. B3LYP-D3 within unrestricted scheme. Intermolecular contacts in the crystal structure were calculated and quantified by examination of Hirshfeld surface and fingerprint plots. In addition, the pharmacological properties of the newly synthesized complex were examined to explore the in vitro antibiofilm activity against P. aeruginosa, and anticancer activity against Human breast adenocarcinoma (MCF-7) cell line. Furthermore, molecular docking study was also recorded to find out various modes of virtual interactions between the zinc complex cation and the active site of receptor (PDB: 1gzt).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
